Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation-Reference-Cited by-同舟云学术

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation

Published:2020-10 Issue:4 Volume:73 Page:896-905
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Bates Jamie^ORCID,Vijayakumar Archana,Ghoshal Sarani,Marchand Bruno,Yi Saili,Kornyeyev Dmytro^ORCID,Zagorska Anna,Hollenback David,Walker Katie,Liu Kathy,Pendem Swetha,Newstrom David,Brockett Robert^ORCID,Mikaelian Igor,Kusam Saritha,Ramirez Ricardo^ORCID,Lopez David,Li Li,Fuchs Bryan C.^ORCID,Breckenridge David G.

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Burden of illness and economic model for patients with Non-Alcoholic Steatohepatitis (NASH) in the United States;Younossi;Hepatology,2019

2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

3. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease;Angulo;Gastroenterology,2015

4. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

5. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites;Neuschwander-Tetri;Hepatology,2010

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Isoliensinine as a Ferroptosis Suppressor with Iron-Chelating Activity;Journal of Natural Products;2024-08-19

2. Cryptotanshinone alleviates liver fibrosis via inhibiting STAT3/CPT1A-dependent fatty acid oxidation in hepatic stellate cells;Chemico-Biological Interactions;2024-08

3. Effects of Picroside Regulating the lncRNA-MALAT1/miR-21/PPAR Signaling Pathway in Fat Synthesis of Patients with Gestational Diabetes Mellitus;International Journal of Pharmacology;2024-08-01

4. Potential therapeutic strategies for MASH: from preclinical to clinical development;Life Metabolism;2024-07-06

5. Metabolic reprogramming in liver fibrosis;Cell Metabolism;2024-07